Findings seen among women with estrogen receptor-positive, axillary node-negative breast cancer<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
THURSDAY, Feb. 23, 2023 (HealthDay News) — Social determinants of health and tumor biology contribute roughly equally to racial disparities in cancer-related death among Black and White women with breast cancer, according to a study published online Feb. 16 in JAMA Oncology<\/em>.<\/p>\n Kent F. Hoskins, M.D., from the University of Illinois at Chicago, and colleagues estimated the proportion of the Black-White disparity in breast cancer survival from estrogen receptor-positive, axillary node-negative breast cancer that is associated with adverse social determinants and high-risk tumor biology. The Surveillance, Epidemiology, and End Results Oncotype registry was used to identify 60,137 women diagnosed between 2004 and 2015 with follow-up through 2016.<\/p>\n The researchers found that the age-adjusted hazard ratio for breast cancer mortality among Black compared with White women was 1.82; neighborhood disadvantage and insurance status together mediated 19 percent of the disparity (mediated hazard ratio, 1.62), and tumor biological characteristics mediated 20 percent (mediated hazard ratio, 1.56). Forty-four percent of the racial disparity (mediated hazard ratio, 1.38) was accounted for in a fully adjusted model including all covariates. For probability of high-risk recurrence score, neighborhood disadvantage mediated 8 percent of the racial difference.<\/p>\n “Racial differences in indicators of aggressive tumor biology that included a genomic biomarker mediated the same proportion of the survival disparity as individual and neighborhood disadvantage,” the authors write.<\/p>\n Several authors disclosed financial ties to the pharmaceutical industry.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n